Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

Cg Oncology Inc (NASDAQ: CGON) closed the day trading at $33.47 down -0.65% from the previous closing price of $33.69. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 0.76 million shares were traded. CGON stock price reached its highest trading level at $33.84 during the session, while it also had its lowest trading level at $32.08.

Ratios:

For a better understanding of CGON, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.15 and its Current Ratio is at 22.15. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on August 19, 2025, initiated with a Overweight rating and assigned the stock a target price of $55.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 05 ’25 when Mulay James sold 27,015 shares for $31.53 per share. The transaction valued at 851,797 led to the insider holds 0 shares of the business.

JAMES MULAY bought 27,015 shares of CGON for $835,844 on Sep 05 ’25. On Sep 03 ’25, another insider, Song Hong Fang, who serves as the Director of the company, sold 100,000 shares for $27.80 each. As a result, the insider received 2,779,542 and left with 2,903,931 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2552007168 and an Enterprise Value of 1891948544. For the stock, the TTM Price-to-Sale (P/S) ratio is 4640.01 while its Price-to-Book (P/B) ratio in mrq is 3.81. Its current Enterprise Value per Revenue stands at 3433.663 whereas that against EBITDA is -12.044.

Stock Price History:

The Beta on a monthly basis for CGON is 0.75, which has changed by -0.08301371 over the last 52 weeks, in comparison to a change of 0.1725707 over the same period for the S&P500. Over the past 52 weeks, CGON has reached a high of $40.47, while it has fallen to a 52-week low of $14.80. The 50-Day Moving Average of the stock is 24.99%, while the 200-Day Moving Average is calculated to be 23.74%.

Shares Statistics:

Over the past 3-months, CGON traded about 848.92K shares per day on average, while over the past 10 days, CGON traded about 943150 shares per day. A total of 76.23M shares are outstanding, with a floating share count of 47.07M. Insiders hold about 38.27% of the company’s shares, while institutions hold 77.36% stake in the company. Shares short for CGON as of 1755216000 were 10328902 with a Short Ratio of 12.17, compared to 1752537600 on 10782077. Therefore, it implies a Short% of Shares Outstanding of 10328902 and a Short% of Float of 14.34.

Earnings Estimates

The company has 9.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.43 and low estimates of -$0.67.

Analysts are recommending an EPS of between -$1.75 and -$2.3 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$2.12, with 9.0 analysts recommending between -$0.9 and -$3.8.